If he hits those milestones it’s not unrealistic for this to be...

If he hits those milestones it’s not unrealistic for this to be $1 a share, the hype of a rumoured Phillips deal brought it to 37cent last year.

It’s now a much more solid business since then. A positive Ramsey trial and an intention to roll it out within their network for me will be as big as Phillips.

People have overlooked that trial, a $15bn market cap hospital group paying to trial the product.....

It’s just not a “cool” business, detecting pain in aged care and hospitals doesn’t have the flare to it like MYQ has.


Anyways @Tarvold, you better be careful with comments regarding CEO’s on here, learn from experience......